This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Abstract
Prior to metastasis, modern therapeutics and surgical intervention can provide a favorable long-term survival for patients diagnosed with many types of cancers. However, prognosis is poor for patients with metastasized disease. Melanoma is the deadliest form of skin cancer, yet in situ and localized, thin melanomas can be biopsied with little to no postsurgical follow-up. However, patients with metastatic melanoma require significant clinical involvement and have a 5-year survival of only 34% to 52%, largely dependent on the site of colonization. Melanoma metastasis is a multi-step process requiring dynamic changes in cell surface proteins regulating adhesiveness to the extracellular matrix (ECM), stroma, and other cancer cells in varied tumor microenvironments. Here we will highlight recent literature to underscore how cell adhesion molecules (CAM) contribute to melanoma disease progression and metastasis.
Footnotes
Mol Cancer Res 2021;19:25–37
- Received July 6, 2020.
- Revision received September 8, 2020.
- Accepted September 25, 2020.
- Published first October 1, 2020.
- ©2020 American Association for Cancer Research.
Log in using your username and password
Purchase access
Volume 19, Issue 1
